117 related articles for article (PubMed ID: 18175252)
1. Therapeutic research for depression and insomnia.
McGee V
IDrugs; 2008 Jan; 11(1):10-2. PubMed ID: 18175252
[No Abstract] [Full Text] [Related]
2. Insomnia market.
Gershell L
Nat Rev Drug Discov; 2006 Jan; 5(1):15-6. PubMed ID: 16485342
[No Abstract] [Full Text] [Related]
3. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R
Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
[TBL] [Abstract][Full Text] [Related]
4. CEE-03-310 CeNeS pharmaceuticals.
Eder DN
Curr Opin Investig Drugs; 2002 Feb; 3(2):284-8. PubMed ID: 12020061
[TBL] [Abstract][Full Text] [Related]
5. Ramelteon: new drug. Insomnia: no role for risky placebos.
Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
[TBL] [Abstract][Full Text] [Related]
6. Follow-on drugs and indications: the importance of incremental innovation to medical practice.
Cohen J; Kaitin K
Am J Ther; 2008; 15(1):89-91. PubMed ID: 18223359
[No Abstract] [Full Text] [Related]
7. Drug therapy and the elderly patient.
Michaels E
Can Med Assoc J; 1983 Jun; 128(12):1442, 1446-7. PubMed ID: 6850470
[No Abstract] [Full Text] [Related]
8. Sleep and depression - theory and practice.
Berk M
Aust Fam Physician; 2009 May; 38(5):302-4. PubMed ID: 19458799
[TBL] [Abstract][Full Text] [Related]
9. [On the pharmacological effects of an association of haloperidol and isopropamide bromide].
Fiume S
Clin Ter; 1966 Oct; 39(2):161-6. PubMed ID: 5996918
[No Abstract] [Full Text] [Related]
10. Experimental pharmacotherapeutics for schizophrenia and addiction.
Jahnke U
IDrugs; 2008 Jan; 11(1):7-9. PubMed ID: 18175251
[No Abstract] [Full Text] [Related]
11. Therapies targeting pain.
Jahnke U; McGee V
IDrugs; 2008 Jan; 11(1):13-5. PubMed ID: 18175253
[No Abstract] [Full Text] [Related]
12. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
Lasch K; Joish VN; Zhu Y; Rosa K; Qiu C; Crawford B
Curr Med Res Opin; 2009 Jul; 25(7):1699-710. PubMed ID: 19505198
[TBL] [Abstract][Full Text] [Related]
13. Opening up new avenues for insomnia treatment research.
Buysse DJ
Sleep; 2003 Nov; 26(7):786-7. PubMed ID: 14655907
[No Abstract] [Full Text] [Related]
14. Insomnia, depression, and distress among outpatients with prostate cancer.
Dirksen SR; Epstein DR; Hoyt MA
Appl Nurs Res; 2009 Aug; 22(3):154-8. PubMed ID: 19616162
[TBL] [Abstract][Full Text] [Related]
15. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.
Wafford KA; Ebert B
Nat Rev Drug Discov; 2008 Jun; 7(6):530-40. PubMed ID: 18511929
[TBL] [Abstract][Full Text] [Related]
16. Drugs for insomnia.
Treat Guidel Med Lett; 2009 Mar; 7(79):23-6. PubMed ID: 19229159
[No Abstract] [Full Text] [Related]
17. Sleep challenges of a 24/7 global society.
Rosekind MR
Manag Care; 2006 Sep; 15(9 Suppl 6):15-6, 17. PubMed ID: 18504886
[No Abstract] [Full Text] [Related]
18. Practical diagnostic strategies and tools for insomnia.
Doghramji PP
Postgrad Med; 2004 Dec; 116(6 Suppl Insomnia):14-22. PubMed ID: 19667687
[TBL] [Abstract][Full Text] [Related]
19. Pain management--Visiongain's fourth annual conference. Exploring recent developments in pain therapy.
Jain K
IDrugs; 2008 Jan; 11(1):27-9. PubMed ID: 18175258
[No Abstract] [Full Text] [Related]
20. Insomnia in special populations: effects of aging, menopause, chronic pain, and depression.
Ancoli-Israel S; Soares CN; Gaeta R; Benca RM
Postgrad Med; 2004 Dec; 116(6 Suppl Insomnia):33-47. PubMed ID: 19667689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
